India to Switzerland: Saxagliptin Export Trade Route

The India to Switzerland Saxagliptin corridor is one of India's established pharmaceutical export routes, with 19 shipments documented worth a combined $728 USD. The route is dominated by LAWRENCE WALTER , which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's saxagliptin manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $38 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with saxagliptin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 19.0%, placing it at rank #5 among India's top saxagliptin export destinations globally.

On the import side, key buyers of Indian saxagliptin in Switzerland include Trans Sped AG - SMI . Trans Sped AG - SMI is the single largest importer with 19 shipments valued at $728 USD.

India's saxagliptin exports to Switzerland are driven primarily by a handful of large-scale manufacturers. LAWRENCE WALTER with 19 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Switzerland benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — LAWRENCE WALTER — together account for 100% of total trade value on this route. The average shipment value of $38 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, Trans Sped AG - SMI is the largest importer with 19 shipments worth $728 USD — representing 100% of all saxagliptin imports from India on this route.